Concepedia

Rimal Bera

RB

Statistics

Publications

5

Citations

208

H-Index

5

Active since

2002

Affiliations

University of California, Irvine(Current)

University of California, Irvine Medical Center

Otsuka (United States)

AstraZeneca (United States)

Rimal Bera is an author at University of California, Irvine specializing in pharmacotherapy, pharmacokinetics, and medicine.

Top concepts

Publications per year

2002–2022

5

Publications

5

Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia

Steven G. Potkin, Rimal Bera, Donna Zubek et al. · BMC Psychiatry · 2013 · 78 citations · Full text

The Safety and Pharmacokinetics of Quetiapine When Coadministered With Haloperidol, Risperidone, or Thioridazine

Steven G. Potkin, Per T. Thyrum, Gustavo Alva et al. · Journal of Clinical Psychopharmacology · 2002 · 70 citations

Impact on healthcare resource usage and costs among Medicaid-insured schizophrenia patients after initiation of treatment with long-acting injectable antipsychotics

Rimal Bera, Steve Offord, Donna Zubek et al. · Journal of Medical Economics · 2013 · 26 citations · Full text

Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability

Steven G. Potkin, Per T. Thyrum, Rimal Bera et al. · Clinical Therapeutics · 2002 · 23 citations

, , +6

Clinician Perceptions of the Negative Impact of Telehealth Services in the Management of Drug-Induced Movement Disorders and Opportunities for Quality Improvement: A 2021 Internet-Based Survey

Rimal Bera, Morgan Bron, Betsy Benning et al. · Neuropsychiatric Disease and Treatment · 2022 · 11 citations · Full text

1–5 of 5